Arrowstreet Capital, Limited Partnership Palatin Technologies Inc Transaction History

Arrowstreet Capital, Limited Partnership

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$0.68 - $1.25 $368,597 - $677,568	-542,055 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$0.38 - $0.78 $751,605 - $1.54 Million	-1,977,910 Reduced 78.49%	542,055 $366,000
Q3 2020 Nov 12, 2020	BUY	$0.47 - $0.64 $287,342 - $391,274	611,366 Added 32.03%	2,519,965 $1.19 Million
Q2 2020 Aug 12, 2020	BUY	$0.41 - $0.73 $406,556 - $723,868	991,600 Added 108.14%	1,908,599 $977,000
Q1 2020 May 15, 2020	SELL	$0.36 - $0.79 $179,902 - $394,786	-499,730 Reduced 35.27%	916,999 $388,000
Q4 2019 Feb 13, 2020	BUY	$0.75 - $0.89 $828,333 - $982,956	1,104,445 Added 353.67%	1,416,729 $1.11 Million
Q3 2019 Nov 14, 2019	SELL	$0.78 - $1.09 $21,312 - $29,783	-27,324 Reduced 8.05%	312,284 $284,000
Q2 2019 Aug 14, 2019	SELL	$0.98 - $1.64 $832,292 - $1.39 Million	-849,278 Reduced 71.43%	339,608 $394,000
Q1 2019 May 15, 2019	SELL	$0.67 - $1.01 $130,343 - $196,488	-194,543 Reduced 14.06%	1,188,886 $1.17 Million
Q4 2018 Feb 14, 2019	BUY	$0.63 - $1.0 $8,325 - $13,215	13,215 Added 0.96%	1,383,429 $980,000
Q2 2018 Aug 14, 2018	BUY	$0.91 - $1.45 $154,063 - $245,485	169,300 Added 14.1%	1,370,214 $1.33 Million
Q1 2018 May 14, 2018	BUY	$0.84 - $1.18 $862,714 - $1.21 Million	1,027,041 Added 590.68%	1,200,914 $1.31 Million
Q4 2017 Feb 09, 2018	BUY	$0.68 - $1.0 $118,233 - $173,873	173,873	173,873 $149,000

3.02K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.27M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.